Author: Brittney Wheeler

The National Institutes of Health (NIH) is supporting a WashU Medicine effort to track neuroinflammation in the brains of patients with Parkinson’s disease.

Researchers at WashU Medicine have found a way to target the vessels that drain waste from the brain. Rejuvenating those vessels could open the door to new therapies to prevent cognitive decline.

The Jansky/Bander Family Fund, a generous commitment of $1.1 million over five years, has been established to advance critical initiatives within the Section of Movement Disorders in the Department of Neurology at WashU Medicine.

Scientists at WashU Medicine have identified a key component to launching immune activity and overactivity, providing a potential therapeutic target for autoimmune diseases.

According to a new study by WashU Medicine researchers, male and female rats with a chronic pain condition release different amounts of dopamine when given fentanyl because of sex hormones. The findings might help explain why men have higher rates of opioid use and overdose deaths.

WashU Medicine has received a three-year $4.5 million grant from the Carol and Gene Ludwig Family Foundation, with the ultimate goal of developing new treatments for Alzheimer’s disease.

Researchers at WashU Medicine have uncovered why some patients with a rare genetic disorder called primary ciliary dyskinesia have worse lung problems than others with the same disorder.

Lawrence E. Thomas, a member of the WashU Board of Trustees and an alumnus, was honored with a lifetime achievement award by the St. Louis American Foundation.

Researchers at WashU Medicine developed a compound, derived from cannabis, that relieves pain in mice but doesn’t affect the brain, thereby avoiding mind-altering side effects and abuse potential.

Li-Feng Jiang-Xie, a postdoctoral research associate in the Department of Pathology and Immunology at WashU Medicine, has received the 2024 WashU Medicine Bold Pioneer Award.